That downside risk was realized by Genting Berhad (KLSE:GENTING) shareholders over the last year, as the share price declined 34%. That falls noticeably short of the market decline of around 5.7%.

Kits Eyecare's high valuation mirrors SaaS growth stocks, but its low-margin model raises concerns. See more on KTYCF's risks ...